Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study

J. H. Bower, D. M. Maraganore, B. J. Peterson, J. E. Ahlskog, W. A. Rocca

Research output: Contribution to journalArticle

79 Scopus citations

Abstract

The authors studied the association of markers of inflammation with the later development of Parkinson disease (PD) using a case-control design (196 cases and 196 matched controls). The frequency of diseases of immediate-type hypersensitivity was significantly higher in cases than controls. In addition, cases used anti-inflammatory agents less frequently than controls (nonsignificant trend). The results may support the hypothesis that there is an inflammatory component in the pathogenesis of PD.

Original languageEnglish (US)
Pages (from-to)494-496
Number of pages3
JournalNeurology
Volume67
Issue number3
DOIs
StatePublished - Aug 1 2006

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study'. Together they form a unique fingerprint.

  • Cite this